MBAL:CA:TSX-Mackenzie Balanced Allocation ETF (CAD)

ETF | Others |

Last Closing

CAD 25.09

Change

+0.21 (+0.84)%

Market Cap

CAD 0.12B

Volume

3.80K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.17 (+0.52%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.05 (-0.17%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.68 (-2.70%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.35 (+1.00%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.02 (+0.04%)

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.59 (+1.25%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.69 (-2.37%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.13 (-1.19%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.03 (+0.13%)

CAD 2.78B

ETFs Containing MBAL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.95% 56% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.95% 54% F 50% F
Trailing 12 Months  
Capital Gain 9.09% 68% D+ 64% D
Dividend Return 2.10% 54% F 37% F
Total Return 11.19% 70% C- 63% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.29% 50% F 46% F
Dividend Return 3.80% 49% F 40% F
Total Return 0.50% 58% F 24% F
Risk Return Profile  
Volatility (Standard Deviation) 9.48% 52% F 75% C
Risk Adjusted Return 40.04% 45% F 51% F
Market Capitalization 0.12B 66% D+ 37% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.